An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Autor Principal: | Bristy, Israt Zerin |
|---|---|
| Outros autores: | Kabir, Md. Tanvir |
| Formato: | Thesis |
| Idioma: | English |
| Publicado: |
Brac University
2021
|
| Subjects: | |
| Acceso en liña: | http://hdl.handle.net/10361/15619 |
Títulos similares
-
Molecules associated with the development of lung cancer
por: Rahman, Adree, et al.
Publicado: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
por: Shabnam, Musharrat
Publicado: (2018) -
Immunotherapy in the Management of Lung Cancer
por: Tasnim, Humayra
Publicado: (2022) -
Protein biomarkers for Lung Cancer: a bioinformatic approach
por: Jeba, Joynob
Publicado: (2017) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
por: Paul, Pulock
Publicado: (2024)